美国退伍军人COVID-19住院:社区医院与退伍军人健康管理局医院死亡率比较
这项回顾性队列研究利用VHA和Medicare数据,纳入2020年3月1日至2021年12月31日因COVID-19住院的64856名65岁及以上、同时参加VHA和Medicare的退伍军人,比较入住VHA医院(17035人)与社区医院(47821人)的结局。采用逆概率治疗加权平衡可观察特征后,社区医院30天死亡率高于VHA医院(粗死亡率27.1% vs 17.7%,风险调整OR 1.37,95%CI 1.21-1.55,P<.001),30天再入院率低于VHA医院(12.7% vs 14.0%,风险调整HR 0.89,95%CI 0.86-0.92,P<.001)。作者认为VHA需了解死亡率差异的来源,以规划未来COVID-19激增和下一次大流行期间的照护。
要点
- 65岁及以上双 enrollment 退伍军人COVID-19住院中,73.7%(47821/64856)入住社区医院,26.3%(17035/64856)入住VHA医院。
- 社区医院 vs VHA医院:粗30天死亡率27.1%(12951/47821) vs 17.7%(3021/17035),P<.001;风险调整OR 1.37(95%CI 1.21-1.55),P<.001。
- 社区医院 vs VHA医院:30天再入院率12.7%(4898/38576) vs 14.0%(2006/14357),风险调整HR 0.89(95%CI 0.86-0.92),P<.001。
- 社区医院住院中,56.1%(36362/64856)通过Medicare入住,17.7%(11459/64856)通过VHA的Care in the Community项目报销入住。
- 作者认为VHA必须了解死亡率差异的来源,以规划未来COVID-19激增和下一次大流行期间对VHA参保者的照护。
适用人群与场景
- 美国全国性退伍军人队列,年龄≥65岁,同时参加VHA和Medicare,且COVID-19住院前一年内接受过VHA照护,依据主要诊断编码确认COVID-19住院。
- 数据来源为VHA和Medicare,时间范围2020年3月1日至2021年12月31日,涉及美国121家VHA医院和4369家社区医院。
研究设计与关键结果
- 回顾性队列研究,纳入64856名退伍军人(平均[SD]年龄77.6[8.0]岁;63562名男性[98.0%]),比较入住VHA医院(17035人[26.3%])与社区医院(47821人[73.7%])的结局。
- 社区医院住院中,36362人(56.1%)通过Medicare入住,11459人(17.7%)通过VHA的Care in the Community项目报销入住。
- 主要结局30天死亡率:社区医院 vs VHA医院粗死亡率27.1%(12951/47821) vs 17.7%(3021/17035),P<.001;风险调整OR 1.37(95%CI 1.21-1.55),P<.001。
- 次要结局30天再入院率:社区医院 vs VHA医院12.7%(4898/38576) vs 14.0%(2006/14357),风险调整HR 0.89(95%CI 0.86-0.92),P<.001。
- 采用逆概率治疗加权平衡可观察患者特征,包括人口学特征、合并症、入院时机械通气、地区社会脆弱性、至VHA与社区医院的距离以及入院日期。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,VHA必须了解死亡率差异的来源,以规划未来COVID-19激增和下一次大流行期间对VHA参保者的照护。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Veterans Health Administration (VHA) enrollees receive care for COVID-19 in both VHA and non-VHA (ie, community) hospitals, but little is known about the frequency or outcomes of care for veterans with COVID-19 in VHA vs community hospitals.
OBJECTIVE: To compare outcomes among veterans admitted for COVID-19 in VHA vs community hospitals.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used VHA and Medicare data from March 1, 2020, to December 31, 2021, on hospitalizations for COVID-19 in 121 VHA and 4369 community hospitals in the US among a national cohort of veterans (aged ≥65 years) enrolled in both the VHA and Medicare with VHA care in the year prior to hospitalization for COVID-19 based on the primary diagnosis code.
EXPOSURE: Admission to VHA vs community hospitals.
MAIN OUTCOMES AND MEASURES: The main outcomes were 30-day mortality and 30-day readmission. Inverse probability of treatment weighting was used to balance observable patient characteristics (eg, demographic characteristics, comorbidity, mechanical ventilation on admission, area-level social vulnerability, distance to VHA vs community hospitals, and date of admission) between VHA and community hospitals.
RESULTS: The cohort included 64 856 veterans (mean [SD] age, 77.6 [8.0] years; 63 562 men [98.0%]) dually enrolled in the VHA and Medicare who were hospitalized for COVID-19. Most (47 821 [73.7%]) were admitted to community hospitals (36 362 [56.1%] admitted to community hospitals via Medicare, 11 459 [17.7%] admitted to community hospitals reimbursed via VHA's Care in the Community program, and 17 035 [26.3%] admitted to VHA hospitals). Admission to community hospitals was associated with higher unadjusted and risk-adjusted 30-day mortality compared with admission to VHA hospitals (crude mortality, 12 951 of 47 821 [27.1%] vs 3021 of 17 035 [17.7%]; P < .001; risk-adjusted odds ratio, 1.37 [95% CI, 1.21-1.55]; P < .001). Readmission within 30 days was less common after admission to community compared with VHA hospitals (4898 of 38 576 [12.7%] vs 2006 of 14 357 [14.0%]; risk-adjusted hazard ratio, 0.89 [95% CI, 0.86-0.92]; P < .001).
CONCLUSIONS AND RELEVANCE: This study found that most hospitalizations for COVID-19 among VHA enrollees aged 65 years or older were in community hospitals and that veterans experienced higher mortality in community hospitals than in VHA hospitals. The VHA must understand the sources of the mortality difference to plan care for VHA enrollees during future COVID-19 surges and the next pandemic.
参考来源
- Ohl ME, Richardson Miell K, Beck BF, et al. Mortality Among US Veterans Admitted to Community vs Veterans Health Administration Hospitals for COVID-19. JAMA Netw Open. 2023. PMID: 37252740. doi:10.1001/jamanetworkopen.2023.15902
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。